Extracellular vesicles mediate antibody-resistant transmission of SARS-CoV-2
Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global pandemic. Antibody resistance dampens neutralizing antibody therapy and threatens current global Coronavirus (COVID-19) vaccine campaigns. In addition to the emergence of resistant SARS-CoV-2 variants, little i...
Main Authors: | Bingqing Xia, Xiaoyan Pan, Rong-Hua Luo, Xurui Shen, Shuangqu Li, Yi Wang, Xiaoli Zuo, Yan Wu, Yingqi Guo, Gengfu Xiao, Qiguang Li, Xin-Yan Long, Xiao-Yan He, Hong-Yi Zheng, Ying Lu, Wei Pang, Yong-Tang Zheng, Jia Li, Lei-Ke Zhang, Zhaobing Gao |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2023-01-01
|
Series: | Cell Discovery |
Online Access: | https://doi.org/10.1038/s41421-022-00510-2 |
Similar Items
-
Impact of SARS-CoV-2 envelope protein mutations on the pathogenicity of Omicron XBB
by: Yi Wang, et al.
Published: (2023-07-01) -
Why is the SARS-CoV-2 Omicron variant milder?
by: Bingqing Xia, et al.
Published: (2022-07-01) -
Mesenchymal Stem Cell-Derived Extracellular Vesicles in Liver Immunity and Therapy
by: Ruiqi Wu, et al.
Published: (2022-03-01) -
Labeling tumor-associated extracellular vesicles with antibody-DNA conjugates for quantitative analysis
by: Xiao Du, et al.
Published: (2025-01-01) -
Schistosoma japonicum extracellular vesicle proteins serve as effective biomarkers for diagnosing parasite infection
by: Huixin Wu, et al.
Published: (2024-05-01)